Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

Early clinical trial evaluates orbofiban pharmacodynamics

April 7, 1998

First clinical trials performed with BMS-181885

April 7, 1998

Phase Ib results reported for allosteric Hb modifier RSR13

April 7, 1998

Novel antisecretory/antiulcer agent from Shionogi undergoes evaluation in Japan

April 7, 1998

YM-905 shows promising activity in animal model of IBS

April 6, 1998

YM-905 shows promise as safe and effective treatment for overactive detrusor

April 6, 1998

Genetronics' EPT plus bleomycin looks effective in prostate cancer

April 6, 1998

Antiplatelet and antithrombotic effects of FR-171113 in guinea pigs

April 6, 1998

Leukocyte activation inhibitor active in animal models of myocardial infarction

April 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...